Skip to content

Home Use of Automatic External Defibrillators to Treat Sudden Cardiac Arrest

Home Automatic External Defibrillator Trial -- HAT

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00047411
Acronym
HAT
Enrollment
7001
Registered
2002-10-04
Start date
2002-09-30
Completion date
2007-09-30
Last updated
2008-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Death, Sudden, Cardiac, Heart Diseases, Myocardial Infarction

Keywords

CPR, AED

Brief summary

To compare home use of an automatic external defibrillator (AED) to the use of local emergency medical system in treating survivors of sudden cardiac arrest.

Detailed description

BACKGROUND: Sudden cardiac arrest (SCA) occurs every two minutes throughout the United States, with more than 70 percent occuring at home. Because survival falls 10 percent per minute over the first ten minutes, it is imperative to defibrillate as soon as possible. Public efforts cannot provide defibrillation fast enough in most cases. Physicians believe the initial shock is best done using readily available AEDs by family members who are only seconds from their loved one. DESIGN NARRATIVE: This study tests the central hypothesis that providing an AED for home use will improve survival beyond that achieved from the typical response to sudden cardiac arrest. An estimated 7,000 people who have had an anterior myocardial infarction will be randomly assigned to one of two groups: 1) a standard response to sudden cardiac arrest, entailing calling an emergency medical service (EMS) system and performing CPR, or 2) the addition of a home AED to the standard response. The standard response will be augmented and standardized by the provision of a video on how to respond to sudden cardiac arrest and how to perform CPR. The goal for the standard response will be immediate notification of EMS and prompt CPR. The goal for the AED group will be to shock the cardiac arrest victim up to three times immediately, if indicated by the AED, and call EMS and perform CPR as soon as possible and preferably within two minutes of collapse. Participants will be enrolled for more than two years and followed for an additional two years. The study will be performed at 200 cardiology clinics.

Interventions

OTHERCardiopulmonary Resuscitation

Immediate notification of EMS by telephone and prompt initiation of CPR, in accordance with published Basic Life Support guidelines

DEVICEAutomatic External Defibrillation

Use the AED first, in accordance with published guidelines for AED use, followed by a call to EMS and perform CPR as in the control group.

Sponsors

Philips Medical Systems
CollaboratorINDUSTRY
Laerdal Medical
CollaboratorINDUSTRY
National Heart, Lung, and Blood Institute (NHLBI)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* History of anterior myocardial infarction * Live-in spouse or companion willing to administer CPR or AED therapy plus CPR

Exclusion criteria

* Existing implantable cardiac defibrillator or AED * Current candidate for an implantable cardiac defibrillator * Current Do Not Resuscitate orders

Design outcomes

Primary

MeasureTime frame
All-cause mortality (measured throughout the study)Five interim analyses of the data were performed and reviewed by the DSMB

Secondary

MeasureTime frame
Survival in the home from cardiac arrest and survival with AED use.Five interim analyses of the data were performed and reviewed by the DSMB
Quality of life of the participants and their spouses (measured throughout the study)Five interim analyses of the data were performed and reviewed by the DSMB

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 5, 2026